KORRO BIO
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. In 2018,
KORRO BIO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.korrobio.com
Total Employee:
51+
Status:
Active
Total Funding:
207.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sixty Degree Capital
Sixty Degree Capital investment in Series B - Korro Bio
Point72
Point72 investment in Series B - Korro Bio
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series B - Korro Bio
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Korro Bio
Surveyor Capital
Surveyor Capital investment in Series B - Korro Bio
Invus
Invus investment in Series B - Korro Bio
New Enterprise Associates
New Enterprise Associates investment in Series B - Korro Bio
Qiming Venture Partners USA
Qiming Venture Partners USA investment in Series B - Korro Bio
Verition Fund Management
Verition Fund Management investment in Series B - Korro Bio
Monashee Investment Management
Monashee Investment Management investment in Series B - Korro Bio
Official Site Inspections
http://www.korrobio.com Semrush global rank: 2.96 M Semrush visits lastest month: 5.49 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago